Drug intelligence / Profile preview

etoricoxib + thiocolchicoside

Development stage
Unknown
Lead developer
Auriga Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

Etoriga-T is an oral fixed-dose combination tablet containing the selective cyclooxygenase-2 (COX-2) inhibitor etoricoxib and the centrally acting muscle relaxant thiocolchicoside. Developed and marketed by Auriga Laboratories, it is indicated for the treatment of acute pain, inflammation, and muscle spasms associated with musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and low back pain. Etoricoxib provides anti-inflammatory and analgesic effects by inhibiting prostaglandin synthesis, while thiocolchicoside acts as a competitive GABAA receptor antagonist and glycine receptor agonist to reduce muscle stiffness and spasms without causing significant sedation.

Brand names
Etoriga-T
Other names
etoricoxib + thiocolchicosideetoricoxib and thiocolchicosideetoricoxib/thiocolchicoside
02

Targets

GABRR (GABA-A receptor subunit rho)Glycine receptorNicotinic Acetylcholine ReceptorPGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on etoricoxib + thiocolchicoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on etoricoxib + thiocolchicoside.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call